Get started
Author

Monica Camou

Observed name: M. Camou
Observed institution: Banner MD Anderson Cancer Center
OpenAlex ID: A5106348645
Successful treatment of PD1-inhibitor induced psoriasiform dermatitis using IL-17 blockade without compromising immunotherapy efficacy
2024 · Adina Greene, Scott Penner, et al. · Journal of Oncology Pharmacy Practice · 4
Treatment of Leptomeningeal Disease with Tepotinib in a Patient with Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Presenting with Extensive Metastasis Involving Duodenum
2025 · Jacquelyn Shugarts, Aida Amado, et al. · Reports — Medical Cases Images and Videos · 2
PDF
First Documented Response to Tarlatamab in a Patient With Transformed SCLC Without Actionable Gene Alteration: Case Report
2026 · Brandon Poppe, Taylor Praska, et al. · JTO Clinical and Research Reports · 1
PDF
Avoiding surgical resection of recurrent BRAF V600E–mutated iodine-refractory papillary thyroid cancer involving trachea/thyroid cartilage via resensitization with dabrafenib and trametinib: report of 3 cases
2025 · Melissa Papuc, Rosemarie Metzger, et al. · The American Journal of Managed Care
Osimertinib-Induced Hepatitis Following Immunotherapy in a Patient with Lung Adenocarcinoma Harboring De Novo EGFR Exon 19 Deletion and T790M Mutations: A Case Report
2025 · Bradley Steiner, Amanda Edmond, et al. · Reports — Medical Cases Images and Videos
PDF
1930P Resensitization of BRAF-mutated radioactive iodine refractory differentiated thyroid cancer with longer duration of dabrafenib and trametinib
2024 · J.J. Niu, K. Milas, et al. · Annals of Oncology
Works count: 6
Citation count: 7
H-index: 2
I10-index:
Year
Topic
Type